Profile data is unavailable for this security.
About the company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
- Revenue in USD (TTM)911.98m
- Net income in USD145.42m
- Incorporated2007
- Employees1.33k
- LocationInspire Medical Systems Inc5500 Wayzata Blvd Ste 1600GOLDEN VALLEY 55416-1237United StatesUSA
- Phone+1 (763) 957-5037
- Fax+1 (302) 655-5049
- Websitehttps://www.inspiresleep.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.33bn | 330.00 | -- | 7.13 | -- | 17.88 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Conmed Corp | 1.37bn | 47.06m | 1.41bn | 3.90k | 30.27 | 1.37 | 11.64 | 1.03 | 1.51 | 1.51 | 44.20 | 33.36 | 0.5936 | 1.78 | 5.66 | 352,493.60 | 2.03 | 2.11 | 2.33 | 2.41 | 54.59 | 54.98 | 3.42 | 3.78 | 1.01 | 3.30 | 0.447 | 51.06 | 5.18 | 9.77 | -64.47 | 37.66 | 8.76 | -5.59 |
| Procept Biorobotics Corp | 308.05m | -95.57m | 1.46bn | 888.00 | -- | 3.99 | -- | 4.74 | -1.72 | -1.72 | 5.55 | 6.50 | 0.5912 | 1.76 | 3.69 | 346,907.70 | -18.34 | -23.13 | -20.70 | -25.70 | 63.70 | 58.76 | -31.02 | -56.52 | 5.77 | -- | 0.1236 | -- | 37.22 | 109.04 | -4.55 | -- | 109.29 | -- |
| Enovis Corp | 2.25bn | -1.18bn | 1.47bn | 7.80k | -- | 0.9868 | -- | 0.6544 | -20.69 | -20.72 | 39.39 | 26.05 | 0.5256 | 1.66 | 5.29 | 288,137.50 | -27.63 | -7.98 | -31.84 | -9.05 | 58.16 | 56.87 | -52.57 | -24.34 | 1.04 | 1.06 | 0.465 | -- | 6.66 | -6.05 | -42.80 | -- | 11.45 | -- |
| Novocure Ltd | 655.35m | -136.23m | 1.54bn | 1.61k | -- | 4.47 | -- | 2.35 | -1.22 | -1.22 | 5.88 | 3.03 | 0.6409 | 4.35 | 8.01 | 408,319.60 | -13.32 | -11.74 | -25.57 | -15.63 | 74.73 | 76.71 | -20.79 | -23.31 | 2.71 | -- | 0.3642 | -- | 8.28 | 5.80 | 19.21 | -- | 12.23 | -- |
| Quidelortho Corp | 2.73bn | -1.13bn | 1.54bn | 6.50k | -- | 0.799 | -- | 0.5636 | -16.66 | -16.66 | 40.25 | 28.28 | 0.4478 | 2.62 | 7.12 | 420,030.80 | -18.56 | -6.45 | -22.13 | -7.39 | 46.67 | 53.89 | -41.45 | -14.40 | 0.9002 | 0.3677 | 0.5798 | -- | -1.89 | 10.44 | 44.84 | -- | 23.72 | -- |
| AtriCure Inc | 534.53m | -11.45m | 1.54bn | 1.35k | -- | 3.13 | 169.62 | 2.88 | -0.241 | -0.241 | 11.19 | 9.88 | 0.8461 | 1.74 | 8.42 | 395,946.70 | -1.81 | -2.67 | -2.07 | -2.98 | 74.98 | 74.88 | -2.14 | -4.13 | 2.99 | -6.75 | 0.1232 | -- | 14.88 | 20.95 | 74.39 | -- | 23.40 | -- |
| UFP Technologies Inc | 602.80m | 68.31m | 1.58bn | 4.15k | 23.28 | 3.72 | 18.02 | 2.61 | 8.78 | 8.78 | 77.44 | 54.96 | 0.9389 | 4.96 | 7.19 | -- | 10.64 | 10.57 | 12.06 | 12.07 | 28.27 | 27.60 | 11.33 | 11.12 | 1.52 | 9.46 | 0.2422 | -- | 19.50 | 27.43 | 15.82 | 38.57 | -- | -- |
| AxoGen Inc | 225.21m | -15.70m | 1.59bn | 622.00 | -- | 11.23 | -- | 7.06 | -0.3413 | -0.3413 | 4.77 | 2.73 | 1.06 | 1.53 | 8.96 | 362,070.80 | -7.38 | -10.17 | -8.46 | -11.70 | 74.31 | 77.27 | -6.97 | -12.34 | 3.31 | -0.9786 | 0.2732 | -- | 20.21 | 14.93 | -57.60 | -- | -24.36 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -204.71m | 1.72bn | 2.50k | -- | 11.10 | -- | 1.70 | -3.07 | -3.07 | 15.08 | 2.27 | 1.10 | 3.37 | 7.25 | 405,894.40 | -22.15 | -12.88 | -30.13 | -16.00 | 53.81 | 52.12 | -20.17 | -14.32 | 2.02 | -6.00 | 0.6699 | -- | 7.93 | 15.26 | -113.18 | -- | -9.19 | -- |
| Artivion Inc | 441.33m | 9.76m | 1.85bn | 1.80k | 194.04 | 4.11 | 57.28 | 4.18 | 0.1987 | 0.1987 | 9.44 | 9.37 | 0.5273 | 1.82 | 5.22 | 245,183.30 | 1.17 | -1.72 | 1.30 | -1.86 | 64.40 | 64.69 | 2.21 | -3.80 | 2.62 | 1.44 | 0.3278 | -- | 13.59 | 11.75 | 173.17 | -- | 39.74 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.85bn | 1.33k | 13.04 | 2.37 | 11.62 | 2.03 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.87bn | 3.58k | 954.42 | 1.51 | 22.89 | 1.58 | 0.0432 | 0.0432 | 25.70 | 27.36 | 0.5786 | 7.19 | 5.01 | 330,962.30 | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.88 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | 0.00 | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| Alphatec Holdings Inc | 764.16m | -143.36m | 2.04bn | 913.00 | -- | 162.88 | -- | 2.67 | -0.9598 | -0.9598 | 5.09 | 0.2398 | 0.9754 | 1.35 | 7.86 | 836,971.50 | -18.30 | -24.58 | -24.00 | -31.32 | 69.60 | 67.58 | -18.76 | -32.07 | 1.28 | -1.28 | 0.9402 | -- | 24.95 | 39.46 | 11.57 | -- | 16.50 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 2.05bn | 699.00 | -- | 7.89 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
| Establishment Labs Holdings Inc | 211.08m | -51.06m | 2.23bn | 1.02k | -- | 93.90 | -- | 10.57 | -1.74 | -1.74 | 7.17 | 0.8104 | 0.5997 | 0.788 | 2.96 | -- | -14.51 | -27.03 | -18.45 | -33.98 | 69.32 | 66.79 | -24.19 | -39.79 | 2.00 | -1.29 | 0.9131 | -- | 27.14 | 20.04 | 39.64 | -- | -- | -- |
Data as of Mar 02 2026. Currency figures normalised to Inspire Medical Systems Inc's reporting currency: US Dollar USD
49.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.19m | 10.96% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.74m | 9.44% |
| Wellington Management Co. LLPas of 31 Dec 2025 | 2.11m | 7.27% |
| D. E. Shaw & Co. LPas of 31 Dec 2025 | 1.21m | 4.17% |
| William Blair Investment Management LLCas of 31 Dec 2025 | 1.16m | 4.00% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 1.10m | 3.79% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 918.50k | 3.16% |
| Artisan Partners LPas of 31 Dec 2025 | 785.74k | 2.70% |
| Fuller & Thaler Asset Management, Inc.as of 31 Dec 2025 | 668.10k | 2.30% |
| Braidwell LPas of 31 Dec 2025 | 540.89k | 1.86% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
